Advanced Gastroenterology Associates, LLC

G.I. Research

Advanced Gastroenterology Associates, LLC, conducts research in selected areas of concern to our patients. Our team participates in research for 2 reasons:

  1. To stay ahead of the latest G.I. treatments by participating in the development and delivery of care. We estimate that we can be 5 years ahead of current methods.
  2. Provide a way to help less fortunate patients who may not be able to afford state of the art G.I. medical treatments.

We conduct our research studies at our Palm Harbor facility.Volunteering to be in a research trial will assist in the development of new medical therapies that may offer better treatments and even cures for life threatening and chronic diseases. Our research trials are regulated by the federal governement and also reviewed by independent ethics committees.

Please contact us in our Palm Harbor office or complete the Research Form.
Note: Be sure to download and complete the New Patient Forms before your visit.

Key points about our research:

  • Insurance is not necessary.
  • Study volunteers may be compensated for time and travel.
  • Study availability changes frequently so please contact our research office for updated status about enrolling trials.
  • Trials open and close at a rapid pace.
  • We will continue to update our research page to keep our patients up to date on the newest research trials.

Resources regarding Clinical Trials ~

Clinical Studies at Advanced Gastroenterology Associates, LLC ~

A Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Multiregional, One Year Study to Assess the Efficacy and Safety of Twice Daily Oral Rifaximin Delayed Release Tablets for Induction of Clinical Remission With Endoscopic Response at 16 Weeks Followed by Clinical and Endoscopic Remission at 52 Weeks in Subjects With Active Moderate Crohn's Disease

Eligibility

Major Inclusion Criteria:

  • Moderate, non-fistulizing Crohn's disease in the ileum and/or prior to randomization; and a SES-CD score of ≥7 (confirmed by centralized endoscopy reading).
  • During the Screening Period, the subject will need to have certain average daily scores for abdominal pain and average number of liquid/very soft stools.

Major Exclusion Criteria:

  • Pregnant or lactating females. Females of childbearing (reproductive) potential must have a negative serum pregnancy test at screening and agree to use a highly effective method(s) of contraception throughout their participation in the study. Diagnosis of ulcerative or indeterminate colitis.
  • Diagnosis of Celiac Disease.
  • Bowel surgery within 12 weeks prior to screening and/or has surgery planned or deemed likely for Crohn's disease during the study period.
  • Presence of an ileostomy or colostomy.
  • Known fixed symptomatic stenosis/stricture of the small or large bowel.
  • Had more than one segmental colonic resection.
  • Had more than 3 small bowel resections or symptoms associated with short bowel syndrome.
  • Current evidence of peritonitis.
  • History or evidence of colonic mucosal dysplasia. • History or evidence of adenomatous colonic polyps that have not been removed.
  • Unwilling to be tapered off corticosteroids by Week 8 or the subject is known by the Investigator to be steroid dependent.
  • Has used a biologic within 12 weeks of randomization.
  • Used cyclosporine, tacrolimus, sirolimus, mycophenolate mofetil, or similar drugs within 8 weeks prior to randomization.
  • Had rectal administration of 5-aminosalicylic acid (5-ASA) or corticosteroid enemas/foams/ suppositories within 2 weeks prior to screening visit.

For More information see: https://clinicaltrials.gov/ct2/show/NCT02240108


top of page...
 
“Providing Leading Edge Care ~
With Compassion”
 
  Palm Harbor Office ~ 727-786-0017
        Dr. J. Taunk, M.D.
Dr. S. Amin, D.O.
Dr. M. Onea, M.D.
   
      Dunedin Satellite Office ~
727-734-6415
(Rings to Palm Harbor Office)
               
  Hudson Office ~ 727-862-9436
           
               
  Hudson Office ~ 727-863-2105
        Dr. T. Reddy, M.D.    
      Spring Hill Satellite Office ~
800-224-5169
(Rings to Dr. Reddy’s Hudson Office)
               
  * call 911 in case of emergency
 

Login to our Patient Portal
 
  Open Patient Forms PDF
 

 

Research Coordinator Contact:

 

Joanne Root, CCRC

Certified Clinical Research Coordinator

Joanne Root, CCRC
 
  34041 US Highway 19 North, Suite A
Palm Harbor, FL 34684
Direct Phone ~ 727-216-0768
Fax ~ 727-786-7521
   
  Email ~ research@advancedgastro.com
   
  Like our Facebook research page: